Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ascorbic Acid and FOLFIRINOX in Advanced Pancreatic Cancer
NCT02896907Phase 1Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Oct 2016
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ascorbic acid in pancreatic cancer (PC), sponsored by Sidney Kimmel Comprehensive Cancer Center. Primary endpoint: Number of Participants With Adverse Events as Determined by CTCAE Version 4.03. Started Oct 2016; status: completed.
02
Drugs
ascorbic acid
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT02896907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02896907.